Holen Sie sich die Stockscreener-App
1.10
2.65%
-0.03
Finanzdaten der Spero Therapeutics Inc-Aktie (SPRO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
100.00%
-
|
0.258 | 41.30 | 5.442 | 14.19 |
| Operating Expenses |
27.32%
9.926
|
7.796 | 9.892 | 13.36 | 16.63 |
| Operating Income/Loss |
31.68%
-9.926
|
-7.538 | 31.41 | -7.916 | -2.444 |
| Nonoperating Income/Loss |
11.64%
0.374
|
0.335 | 0.376 | 0.534 | 0.744 |
| Net Income/Loss |
32.61%
-9.552
|
-7.203 | 31.52 | -7.382 | -1.70 |
| Basic Average Shares |
1.20%
57.97
|
57.28 | - | 56.28 | 56.03 |
| Diluted Average Shares |
1.20%
57.97
|
57.28 | - | 56.28 | 56.03 |
| Basic Earnings Per Share |
23.08%
-0.16
|
-0.13 | - | -0.13 | -0.03 |
| Diluted Earnings Per Share |
23.08%
-0.16
|
-0.13 | - | -0.13 | -0.03 |
4.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):